We are live on ! Find out more
ELI

ELITE PHARMACEUTICAL
ELI

Delisted

ELI was delisted on the 20th of May, 2009.

Back to rankings

5 hedge funds and large institutions have $98K invested in ELITE PHARMACEUTICAL in 2015 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 5 → 5 (0)

18% less capital invested

Capital invested by funds: $120K → $98K (-$21.7K)

Holders
5
Holders Change
–
Holders Change %
0%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

ELI Hedge Fund Activity: Q2 2015 in Review

5 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in ELITE PHARMACEUTICAL (ELI) for Q2 2015, worth a combined $98K — down 18% from $120K a quarter earlier.

Fund positioning in ELI was balanced in Q2 2015: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 5 institutional investors held ELITE PHARMACEUTICAL (ELI) as of Q2 2015, unchanged from Q1 2015.
  • Funds reported $98K of ELITE PHARMACEUTICAL stock for Q2 2015, down 18% quarter-over-quarter.
  • 0 funds opened new ELITE PHARMACEUTICAL positions in Q2 2015 and 0 closed out.

Based on aggregated 13F filings for Q2 2015.